ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

NCT03903835 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

750

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer (mCRPC)
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Interventions

DRUG: Enzalutamide Oral Capsule
DRUG: Abiraterone Oral Tablet
DRUG: Carboplatin
DRUG: Cabazitaxel 60 mg Solution for Injection
DRUG: Docetaxel Injectable Solution
DRUG: Radium Chloride Ra-223
DRUG: Niraparib plus Abiraterone acetate plus Prednisone
DRUG: Capivasertib plus Docetaxel
DRUG: Apalutamide
DRUG: Darolutamide

Sponsor

Karolinska Institutet

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]